GUELPH, ON / ACCESS Newswire / January 17, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, is pleased to provide an update on the launch of ZenGUARD™ Enhanced Air Filters in the Canadian Market.

GUELPH, ON / ACCESSWIRE / January 8, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to announce that its wholly owned subsidiary, Albany Graphite Corporation (AGC) has achieved a preliminary five-nines purity of 99.9991% directly from a larger Albany graphite deposit flotation concentrate sample utilizing an operational pilot-scale fluidized bed reactor (FBR).

GUELPH, ON / ACCESSWIRE / December 12, 2024 / Zentek Ltd. (" Zentek "or the " Company ") (NASDAQZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, has signed a Memorandum of Understanding ("MOU") with Al-Ramez International Group - through Saudi Excellence Holding Company - establishing a strategic partnership to drive innovation and commercialization in advanced technologies across the Kingdom of Saudi Arabia ("KSA") and the Middle East and North Africa ("MENA") region on November 14 th 2024.

GUELPH, ON / ACCESSWIRE / December 9, 2024 / Zentek Ltd. ("Zentek"or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, announces that on December 3, 2024, it received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), as the minimum bid price of the Company's common stock ("Common Stock") has been above US $1.00 per share for the last 11 consecutive business days.

GUELPH, ON / ACCESSWIRE / November 27, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, announces its decision that its ZenGUARD™ Enhanced Air Filters will be added under the company's existing medical device establishment licence ("MDEL"), similar to ZenGUARD™ Surgical Masks.

Zentek just reported results for the first quarter of 2025.

Zentek just reported results for the fourth quarter of 2024.

GUELPH, ON / ACCESSWIRE / November 6, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQZTEK)(TSXV:ZEN), announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera") has received a $1.1 million Government of Canada contract to test its multivalent aptamer technology for the rapid drug discovery of therapeutics or prophylactics of highly pathogenic avian influenza ("HPAI") A(H5N1).

GUELPH, ON / ACCESSWIRE / October 31, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQZTEK)(TSXV:ZEN), an intellectual property development and commercialization company announces that it has withdrawn its submission to the Health Canada Pest Management Regulatory Agency ("PMRA") for its ZenGUARD™ Enhanced Air Filters. Based on feedback received from PMRA, and continued analysis of the Canadian regulatory environment, the Company believes there are other, more cost-effective, and timely pathways, to bring ZenGUARD™ Enhanced Air Filters to market in Canada. The Company has been evaluating and planning for these potential alternative options in parallel with the PMRA assessment process over the last several months and will now shift its focus to these other pathways.

GUELPH, ON / ACCESSWIRE / October 17, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, is pleased to provide an update on recent commercialization activities for its ZenGUARD™Antimicrobial Surgical Masks.

GUELPH, ON / ACCESSWIRE / August 14, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN) wishes to announce that, subject to regulatory approval, it will conduct a normal course issuer bid (the "Bid"). The Bid will be for up to 5,084,319 common shares of the Company over a period of one year (the "Bid Period"), being approximately 5% of Company's issued and outstanding common shares, with up to 2,033,727 common shares of the Company purchasable over any 30-day period within the Bid Period, being 2% of Company's issued and outstanding common shares. The Bid Period will commence on August 16, 2024, and will continue until the earlier of August 15, 2025, or the date by which the Company has acquired the maximum number of common shares which may be purchased under the Bid.

GUELPH, ON / ACCESSWIRE / August 8, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to announce preliminary battery results and the commencement of a three-year, $441,000 project in collaboration with Professors Mohini Sain and Ning Yan from the University of Toronto ("U of T"). Funding for the project is provided by a Natural Sciences and Engineering Research Council of Canada ("NSERC") Mission Alliance Grant. Prof. Sain is the Endowed Ford Motor Canada Chair in Sustainable Materials and Prof. Yan is the Tier 1 Canada Research Chair in Sustainable Bioproducts.

GUELPH, ON / ACCESSWIRE / July 24, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQZTEK)(TSXV:ZEN), an intellectual property development and commercialization company announces that it will embark on a Canada-wide sampling program for dental professionals facilitated by Henry Schein Inc. ("Henry Schein") that will see ZenGUARD™ Antimicrobial Surgical Masks included in product shipments to Henry Schein customers.

GUELPH, ON / ACCESSWIRE / July 17, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company is pleased to announce that its wholly owned subsidiary, Albany Graphite Corporation (AGC) has achieved a five nines purity of 99.99915% for a graphite sample from the Albany graphite deposit.

GUELPH, ON / ACCESSWIRE / June 21, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQZTEK)(TSXV:ZEN) announces the granting of options to acquire an aggregate of 1,935,000 common shares to certain directors, officers and employees of the Company, exercisable at a price of $1.52 per common share for a period of five years from the date of the grant. For directors and officers, the options will vest one third on the date of grant, one third on the first anniversary of the grant, and one third on the second anniversary of the grant. For employees, the options will vest one quarter on the date of grant, and one quarter on each anniversary thereafter.

GUELPH, ON / ACCESSWIRE / May 27, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company has received a second patent by the Canadian Intellectual Property Office titled: Graphene Oxide-Cationic Silver (GO-Ag+) Nanocomposites and Their Use as a Broad-Spectrum Antimicrobial Agent and includes a total of 64 successful claims. The Company also applied for this patent with the United States Patent and Trademark Office. The patent claims the novel GO-Ag+ compound, that is the active ingredient for ZenGUARD™ , as an effective agent against both regular and resistant bacteria, fungi and viruses. The patent claims liquid, powder and ointments that use GO-Ag+ as the active ingredient.

GUELPH, ON / ACCESSWIRE / May 23, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company and DCL Supply Ltd. ("DCL Supply"), a private Heating, Ventilation and Air Conditioning ("HVAC") master product distributor are pleased to announce that they have entered into a distribution agreement effective March 19th, 2024, for an initial one-year term, and which automatically renews for subsequent one-year terms unless 90 days' notice is given by either party prior to renewal. The initial product to be distributed will be ZenGUARD™ Enhanced Air Filters for the HVAC market, subject to the assessment by the Health Canada Pesticide Management Regulatory Agency for registration under the Pest Control Products Act, which is ongoing. Subject to such registration, this agreement would allow DCL Supply to distribute ZenGUARD™ Enhanced Air Filters through its extensive distributor network serving numerous industrial, commercial and institutional clients within and across Canada.

GUELPH, ON / ACCESSWIRE / May 7, 2024 / Zentek Ltd. (" Zentek " or the " Company ") (NASDAQZTEK)(TSXV:ZEN), an intellectual property development and commercialization company is pleased to announce that it has completed a case study based on the City of Toronto highlighting the economic and environmental benefits related to using MERV 9A filters compared to using MERV 13 filters. The study quantifies cost savings and reductions in carbon emission and waste assuming the City of Toronto is currently using MERV 13 filters in all its buildings and switches to MERV 9A filters.

GUELPH, ON / ACCESSWIRE / May 6, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera") has prioritized the development of a prophylaxis and therapeutic for highly pathogenic avian influenza ("HPAI") and reports initial test results.

GUELPH, ON / ACCESSWIRE / May 3, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces the following changes to its board and management teams: (i) Dr. Francis Dubé has resigned as Chief Operating Officer of the Company effective May 1, 2024, and (ii) Brian Bosse has resigned as a director of the Company effective May 3, 2024, and has been appointed to the Company's advisory board.

GUELPH, ON / ACCESSWIRE / April 25, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to provide an update on its ZenGUARD™ platform. The Company has made significant strides preparing for the launch of ZenGUARD™ Enhanced Air Filters for the Heating, Ventilation and Air Conditioning ("HVAC") market and pursuing new opportunities for surgical masks.

GUELPH, ON / ACCESSWIRE / April 3, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce that it has entered into a definitive distribution agreement with Dallas, Texas-based Medwell Solutions LLC. ("MedWell") for its ZenGUARDTM Enhanced Surgical Masks in the U.S. The agreement was signed on March 18th 2024 and is for a period of two years from the date of facility establishment registration and issuance of market clearance from the U.S. Food and Drug Administration ("FDA"), at which point sales of ZenGUARDTM-Enhanced Surgical Masks can commence.

GUELPH, ON / ACCESSWIRE / March 25, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera") has completed testing demonstrating that its C19HBA SARS-CoV-2 universal aptamer built on the proprietary high-binding affinity aptamer platform has shown a promising safety and toxicity profile in preclinical testing. This is a critical step in the path towards the development of a human therapeutic.

GUELPH, ON / ACCESSWIRE / January 30, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN) announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera")has completed testing of its C19HBA aptamer as a potential therapeutic. The SARS-CoV-2 universal aptamer built on the proprietary high-binding affinity aptamer platform successfully outperformed a leading monoclonal antibody ("LMA") in preclinical testing demonstrating potential as a therapeutic for SARS-CoV-2.

GUELPH, ON / ACCESSWIRE / January 22, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce the completion of a new study highlighting the potential significant energy, emission and cost savings for commercial buildings adopting ZenGUARDTM Enhanced Air Filters.